Loading clinical trials...
Loading clinical trials...
Phase 4, Open-Label, Single-Dose, Parallel-Group Study to Evaluate the Safety of 1 g of Cefazolin in Pediatric Subjects Weighing 25 to Less Than 60 kg and 2 g of Cefazolin in Pediatric Subjects Weighing at Least 60 kg Scheduled for Surgery
Conditions
Interventions
Cefazolin 1 g Infusion
Cefazolin 2 g Infusion
Locations
5
United States
Arkansas Children's Research Institute
Little Rock, Arkansas, United States
University of Missouri Health Care System
Columbia, Missouri, United States
Children's Medical Center Dallas
Dallas, Texas, United States
The University of Texas Health Science Center at Houston
Houston, Texas, United States
Carilion Clinic
Roanoke, Virginia, United States
Start Date
November 20, 2017
Primary Completion Date
July 31, 2019
Completion Date
July 31, 2019
Last Updated
July 13, 2020
NCT05052619
NCT05961930
NCT01838733
NCT06547281
NCT06044428
NCT03990974
Lead Sponsor
B. Braun Medical Inc.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions